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Abstract: Current pet diabetes mellitus (DM) treatment necessitates the active daily involvement
of owners and can be costly. The current study aimed to investigate the owner population which
opts for euthanasia instead of DM treatment. A survey was designed using multiple feedback steps
and made available online to veterinarians world-wide. A total of 1192 veterinarians completed
the survey and suggested a median one in 10 diabetic pets are euthanased at diagnosis; a further
median one in 10 within one year because of lack of success or compliance. Perceived most important
motivating factors included “presence concurrent disease” (45% respondents); “costs” (44%); “animal
age” (37%); “problems obtaining adequate control” (35%); “pet welfare” (35%); and “impact owner’s
lifestyle” (32%). Cats in Canadian (odds ratio (OR) 2.7), Australian (OR 2.3), rural (OR 1.6) and
mixed (OR 1.7) practices were more likely to be euthanased because of DM diagnosis, while cats
presented to referral/university were less likely to be euthanased (OR 0.6). Dogs were more likely
to be euthanased because of DM in Canadian (OR 1.8), rural (OR 1.8) and mixed (OR 1.6) practices.
The survey results suggest that benefit exists in improved DM education with emphasis on offering a
choice of treatment styles ranging from intense and expensive to hands-off and cheap.
Keywords: diabetes mellitus; survey; euthanasia; quality of life; insulin injections
1. Introduction
Owners’ active participation in the treatment is essential for successful management of diabetes
mellitus (DM) in companion animals. The disease and the treatment commitments are likely to
have considerable impact on owners’ daily routines and quality of life (QoL) and might represent a
significant temporal, financial and emotional burden. Several areas of everyday life that are negatively
influenced by DM and its treatment have been identified in a recent survey concerning the QoL of
diabetic cats and dogs and their owners [1,2]. Owners’ perception of substantial impairment in one
or more of these areas could potentially lead to treatment cessation and similar concerns could even
prompt the decision to decline treatment at the time of diagnosis. However, the above mentioned QoL
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survey reflects the views only of those who had already accepted and initiated the treatment and the
assumption that owners who decline or opt to cease treatment share the same concerns might not be
correct. Rationale of the latter group is not well documented.
Epidemiologic data regarding DM and survival of dogs and cats with DM are limited [3,4] and
only a few studies concerning diabetic cats treated at university teaching hospitals (UTHs) provide
some insights to factors associated with mortality [5–7]. However, none of the studies have assessed
the reasons for owners to decline or cease treatment. Moreover, most information stems from UTHs
and large scale studies concerning treatment of DM in private practice are lacking.
The aim of this study was to document the perceived frequency of euthanasia among cats and
dogs with DM at the time of diagnosis and within the first month and first year of treatment, investigate
the possible influence of demographic factors on the decision to decline or cease treatment of DM as
well as identify the owner’s reasons for making this decision and compliance issues. To obtain this
information, the Big Pet Diabetes Survey was designed and performed among veterinary clinicians.
At the same time, this approach allowed assessment of current DM treatment habits and experiences
of participating clinicians.
2. Materials and Methods
2.1. Design of Survey
Qualitative research was conducted as part of the design phase of the Big Pet Diabetes Survey.
To ensure all items were DM-treatment-centred and of specific validity to clinicians, diabetic pets and
their owners, detailed discussions were conducted with 65 veterinary surgeons and 36 nurses (both in
primary practice and in referral practice, both in the UK and USA), as well as a clinical epidemiologist.
This initial phase resulted in the formulation of five demographic questions and 36 specific DM
treatment questions, including quantification of the number of pets being denied treatment, reasons
for such denial, treatment habits and success rates of the participating clinician, as well as perceived
concerns of client and clinician surrounding DM treatment. All questions required the respondent to
choose one multiple choice question answer or a numeric answer. A free comments section at the end
of the survey provided the opportunity for additional comments.
The second phase consisted of the Big Pet Diabetes Survey being digitalised and publicised
online using a software package (Questionmark Perception Manager, Questionmark, London, UK).
An initial trial was conducted amongst 20 veterinary surgeons and 10 veterinary nurses in order to
identify areas of confusion and assess the questions’ true validity. Feedback was used to fine-tune and
finalise the questions and answer categories, before subsequent application of the final online version
(Supplement 1) in the larger veterinary clinician community (third phase). The presented data were
voluntarily provided by veterinarians in the full knowledge that this information facilitated the study
of diabetic pets and their owners; the study was approved by the Royal Veterinary College’s ethics
and welfare committee.
2.2. Recruitment of Respondents
The final digitalised Big Pet Diabetes Survey was made available online using the Uniform
Resource Locator (URL) www.rvc.ac.uk/diabetesvet. Recruitment of respondents was conducted
in 2008 and 2009, parallel with and through the same channels as the diabetic pet owner survey
recruitment as described previously [1,2].
2.3. Statistical Analysis
Descriptive statistics were obtained for all variables using proportion of observations in different
categories for categorical variables, mean and standard deviation (SD) for normally distributed
quantitative variables and median and interquartile range (IQR) for non-normally distributed
quantitative variables. Data regarding the diabetes treatment decision questions were analysed
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through univariate analysis using the non-parametric Kruskall–Wallis test for questions in the format
“out of 10 cats/dogs/owners, how many...”. Multivariate analysis was performed to assess the same
relationships while adjusting for potential confounding effects by selected demographical factors.
For the purpose of reporting the results, the category “practice type I” includes mixed and 100% small
animal practices, and “practice type II” includes referral/university, charity and private practices.
Continental Europe, suburban, 100% small animal and private practices, as well as practices with
<20% of cats/animals insured served as reference category. Once the variables to be included in the
model were identified, ordinal logistic regression was used.
In view of the low frequency of answers indicating four or more for questions in the format “out
of 10 cats/dogs/owners, how many...” and the results of testing for parallel lines (testing for equal
slope coefficients across outcome variables), answers options were re-grouped into five categories,
specifically: 0, 1, 2, 3 and greater or equal to 4. Assessment of the multivariate analysis model was
done by testing for parallel lines; the model was deemed appropriate if p > 0.05.
All statistical analyses were performed using a statistical software package (SPSS 17.0 for
Windows, SPSS Inc., Chicago, IL, USA) and p ≤ 0.05 deemed significant.
3. Results
A total of 1192 veterinarians completed the survey. The majority of respondents worked in
suburban and urban areas of the USA and UK and Ireland. Most of the clinicians worked in 100%
small animal private practice settings, serving a predominantly uninsured patient population and
diagnosed DM in less than six cats and less than six dogs each year (Table 1).
Table 1. Country of origin of 1192 responding veterinary clinicians and breakdown according to
various demographical parameters.
Country or Region
Practicing Clinician
Number of
Respondents (%) Location
Practice
Type I
Practice
Type II
% Cats and
Dogs Insured DM Diagnoses/Year
USA 807 (67.8%)
Rural 95
(11.8%)
Urban 192
(23.8%)
Suburban
509 (63.1%)
Other 11
(1.4%)
SA 715
(89.3%)
Mixed 62
(7.7%)
Other 20
(2.5%)
Private 732
(91.2%)
Charity 9
(1.1%)
Referral/Uni
37 (4.6%)
Other 25
(3.1%)
<20% insured
789 (98%)
>20% insured
16 (2%)
Cats:
<6: 330 (40.9%)
6–10: 282 (34.9%)
>10: 195 (24.2%)
Dogs:
<6: 492 (61.3%)
6–10: 195 (24.3%)
>10: 115 (14.3%)
UK and Ireland 168 (14.1%)
Rural 26
(15.5%)
Urban 72
(42.9%)
Suburban 67
(39.9%)
Other 3
(1.8%)
SA 139
(83.2%)
Mixed 26
(15.6%)
Other 2
(1.2%)
Private 129
(77.2%)
Charity 20
(12%)
Referral/Uni
15 (9%)
Other 3
(1.8%)
<20% insured
59 (35.1%)
>20% insured
109 (64.9%)
Cats:
<6: 90 (53.6%)
6–10: 47 (28.0%)
>10: 31 (18.5%)
Dogs:
<6: 97 (58.1%)
6–10: 43 (25.7%)
>10: 27 (16.2%)
Canada 93 (7.8%)
Rural 10
(10.8%)
Urban 27
(29.0%)
Suburban 54
(58%)
Other 2
(2.2%)
SA 80 (86%)
Mixed 11
(11.8%)
Other 2
(2.2%)
Private 82
(88.2%)
Charity 3
(3.2%)
Referral/Uni
4 (4.3%)
Other 4
(4.3%)
<20% insured
90 (96.8%)
>20% insured
3 (3.2%)
Cats:
<6: 36 (38.7%)
6–10: 36 (38.7%)
>10: 21 (22.6%)
Dogs:
<6: 67 (72.8%)
6–10: 19 (20.4%)
>10: 6 (6.5%)
Continental Europe 93 (7.8%)
Rural 13
(14.1%)
Urban 46
(50%)
Suburban 32
(34.8%)
Other 1
(1.1%)
SA 73
(78.5%)
Mixed 16
(17.2%)
Other 4
(4.3%)
Private 68
(73.1%)
Charity 2
(2.2%)
Referral/Uni
21 (22.6%)
Other 2
(2.2%)
<20% insured
85 (92.4%)
>20% insured
7 (7.6%)
Cats:
<6: 48 (51.6%)
6–10: 32 (34.4%)
>10: 13 (14.0%)
Dogs:
<6: 69 (74.2%)
6–10: 14 (15.1%)
>10: 10 (10.8%)
Australia 29 (2.4%)
Rural 3
(10.3%)
Urban 7
(24.1%)
Suburban 19
(65.5%)
Other 0 (0%)
SA 27
(93.1%)
Mixed 2
(6.9%)
Other 0 (0%)
Private 24
(82.8%)
Charity 1
(3.4%)
Referral/Uni
4 (13.8%)
Other 0 (0%)
<20% insured
29 (100%)
>20% insured
0 (0%)
Cats:
<6: 13 (44.8%)
6–10: 11 (37.9%)
>10: 5 (17.2%)
Dogs:
<6: 19 (65.5%)
6–10: 3 (10.3%)
>10: 7 (24.1%)
DM – Diabetes Mellitus; SA—100% small animal practice; Uni—referral or university practice.
A summary of their DM treatment habits is provided in Table 2.
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Table 2. Description of clinicians’ DM treatment habits.
Parameter Unit
Value
Cats Dogs
Proportion of clinicians prescribing
twice daily insulin injections
Number (percentage)
of clinicians 980 of 1182 (82.9%) 946 of 1132 (83.6%)
Starting insulin dose U/kg BW/injection:mean ± SD 0.45 ± 0.31 0.60 ± 0.52
Number of cats/dogs started on new
diet at diagnosis
Median number of
cats/dogs (IQR) 9 of 10 (6–10) 7 of 10 (3–9)
Number of cats/dogs started on oral
hypoglycaemic drugs at diagnosis
Median number of
cats/dogs (IQR) 0 of 10 (0–0) 0 of 10 (0–0)
BW—body weight; SD—standard deviation; IQR—interquartile range.
A total of 946 (93.2%) and 984 (95.3%) of the clinicians, respectively, reported they would
“certainly” treat their own cat or dog with insulin injections should their pet be diagnosed with DM.
The proportions of cats and dogs euthanased at the time of DM diagnosis, those euthanased
because of injection issues or those ceasing the treatment within 1 month and 1 year of DM diagnosis
are given in Table 3.
Table 3. Answers to questions about main treatment decisions in regards to DM (euthanasia at the time
of diagnosis, at 1 month and 1 year).
Question Number
“Typically, in this practice, out of ten cats or
dogs newly diagnosed with diabetes
mellitus, . . . .” (second part of the question
continued below)
Cats: Median
(IQR)
Dogs: Median
(IQR)
C1/D1 “ . . . how many are euthanased on request ofthe owner at time of diagnosis?” 1 (0–2) 1 (0–1)
C2/D2
“ . . . how many are euthanased on request of
the owner because of not wanting to treat with
insulin injections at time of diagnosis?”
1 (0–1) 0 (0–1)
C3/D3
“ . . . and started on insulin injections, in how
many is insulin treatment subsequently
stopped within 1 month because of lack of
success or compliance?”
0 (0–1) 0 (0–1)
C4/D4
“ . . . and started on insulin injections, in how
many is insulin treatment subsequently
stopped within 1 year because of lack of
success or compliance?”
1 (0–2) 1 (0–2)
IQR—interquartile range.
The opinion of the majority of clinicians (percentage of clinicians in brackets) was that owners
were “probably” (41.8%) or “definitely” (26.7%) more likely to opt for insulin injection therapy when
animals were insured. Clinicians (percentage of clinicians in brackets) also assumed that owners
were “probably” (31.2%) or “definitely” (57.5%) more likely to opt for insulin injections when they
themselves or close family or friends were diabetic.
Factors considered by clinicians (percentage of clinicians in brackets) to be of “great importance”
in the owner’s decision making to euthanase diabetic animals, stop the treatment or not start DM
treatment in the first place were (in decreasing order) “concurrent disease” (45%); “costs” (44%); “age
of the animal” (37%); “problems obtaining adequate control” (35%); “welfare of the pet” (35%); “too
much impact on owner’s lifestyle” (32%); and “injection problems” (17%) (Figure 1).
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The most commonly encountered compliance issues considered to be “of great importance” by
the clinicians (percentage of clinicians in brackets) were “owner does not stick to feeding protocol”
(28%); “owner having injection difficulties” (17%); “cat causing injection difficulties” (15%); “injections
not given at right times” (12%); “inappropriate insulin storage” (9%); and “dog causing injection
difficulties” (8%) (Figure 2).
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Figure 2. Clinicians’ answers to the survey question "According to you how important are the following
compliance issues encountered in your practice?” Compliance issues indicated by numbers on X-axis:
1. owner having injectio difficulties; 2. cat causing injection difficulties; 3. dog causing injection
difficulties; 4. inappropri te insulin storage; 5. injections not given at right times; 6. owner does ot
stick to feeding protocol; 7. other (additional issues reported by the respondents and rated according to
importance).
Based on their experience, clinicians (percentage of clinicians in brackets) considered “QoL of the
animal” (60%); “costs of treatment” (52%); “having to inject their animal” (48%); “lifestyle changes the
owner has to make” (38%); “hypoglycaemia” (23%); and “diabetic ketoacidosis (DKA)” (7%) to be of
“great concern” for owners of diabetic cats and dogs (Figure 3).
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Table 4. Answers to questions about quality of life and frequency of complications of DM. Questions
C6/D6 as well as question 9 relates to owners’ quality of life and difficulties fitting in twice daily
injections, respectively. In question 9, cat and dog owners were not addressed separately.
Question Number
“Typically, in this practice, out of ten cats or
dogs newly diagnosed with diabetes mellitus
(or their owners), . . . .” (second part of the
question continued below)
Cats (Cat Owners):
Median (IQR)
Dogs (Dog Owners):
Median (IQR)
C5/D5
“ . . . how many achieve a satisfactory quality of
life according to the owner once treatment with
insulin injections has been started?”
8 (7–9) 8 (7–9)
C6/D6
“ . . . how many of the owners eventually have a
satisfactory quality of life and not feel limited in
lifestyle because of daily insulin injections?”
8 (6–9) 8 (6–9)
C7/D7
“ . . . how many suffer from an apparent
hypoglycaemic crisis (suggestive clinical signs OR
recorded blood glucose) at some stage during
treatment?“
2 (1–4) 2 (1–3)
C8/D8
“ . . . how many will suffer from an episode of
keto-acidosis (DKA) after insulin treatment has
been initiated?“
1 (0–2) 1 (0–2)
9
“...how many of the owners report having
difficulties fitting in a twice daily injection
treatment instead of a once daily injection
treatment?” a
2 (1–4)
IQR—interquartile range.
3.1. Results of Univariate Analysis
The variables “country”, “location of the practice” and “practice type I” were found to be
significantly associated with the answers to questions D/C 1 (“frequency of euthanasia of newly
diagnosed diabetic dogs/cats at time of diagnosis”) and D/C 2 (“frequency of euthanasia of newly
diagnosed diabetic dogs/cats at time of diagnosis because of not wanting to inject”), and “practice type
II” was associated with the answers to question C 2. “Practice type I” was associated with the answers
to questions D/C 3 and 4. Additionally, “practice location” and “practice type II” were associated
with the answers to question D 3, while “% insured” was associated with the answers to question D 4.
The results of univariate analysis are provided in Supplement 2.
3.2. Results of Multivariate Analysis
Results of multivariate analysis can be seen in Tables 5 and 6.
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Table 5. Results of multivariate analysis for questions C1, C2, D1 and D2.
Factor
Frequency Euthanasia
Newly Diagnosed Diabetic
Cats (C1)
Frequency Euthanasia Newly
Diagnosed Diabetic Dogs D1
Frequency Euthanasia Newly
Diagnosed Diabetic cats—Not
Wanting to Inject C2
Frequency Euthanasia Newly
Diagnosed Diabetic Dogs—Not
Wanting to Inject D2
p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI)
Country
UK and Ireland 0.331 0.75 (0.42–1.34) 0.188 0.67 (0.38–1.21) 0.290 0.72(0.40–1.32) 0.828 0.93 (0.51–1.72)
USA 0.383 0.83 (0.54–1.27) 0.349 0.81 (0.53–1.25) 0.294 0.79(0.51–1.23) 0.835 0.95 (0.61–1.50)
Canada 0.001 2.68 (1.53–4.67) 0.050 1.75 (1–3.08) 0.003 2.36(1.34–4.16) 0.014 2.06 (1.15–3.68)
Australia 0.038 2.26 (1.04–4.88) 0.32 2.38 (1.08–5.27) 0.537 1.28(0.58–2.83) 0.105 1.97 (0.87–4.46)
Cont. Europe a – a – a – a – a
Location
Rural 0.010 1.6 (1.12–2.28) 0.001 1.81 (1.26–2.59) 0.000 2.17(1.51–3.12) 0.000 2.17 (1.51–3.13)
Urban 0.339 1.14 (0.87–1.47) 0.63 1.29 (0.99–1.68) 0.385 1.13(0.86–1.47) 0.300 1.16 (0.88–1.53)
Sub-urban a – a – a – a – a
Practice type I Mixed 0.009 1.69 (1.14–2.50) 0.02 1.59 (1.07–2.35) 0.987
1.00
(0.67–1.51) 0.312 1.23 (0.82–1.85)
SA a – a – a – a – a
Practice type II
Referral/Uni 0.032 0.6 (0.37–0.96) 0.439 0.83 (0.52–1.33) 0.015 0.54(0.33–0.89) 0.560 0.86 (0.53–1.41)
Charity 0.424 1.3 (0.68–2.5) 0.101 1.72 (0.90–3.31) 0.129 1.69(0.86–3.33) 0.597 1.2 (0.61–2.37)
Private – a – a – a – a
% insured
>20% 0.693 1.11 (0.67–1.82) 0.809 0.94 (0.57–1.56) 0.988 1.00(0.59–1.68) 0.562 0.86 (0.51–1.45)
<20% a – a – a – a – a
CI—confidence interval; a Reference category; Bold: Statistically significant association (p ≤ 0.05).
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Table 6. Results of multivariate analysis for questions C3, C4, D3 and D4.
Factor
Frequency Treatment
Stopped Cats <1 Month C3
Frequency Treatment Stopped
Dogs <1 Month D3
Frequency Treatment Stopped
Cats <1 Year C4
Frequency Treatment Stopped
Dogs <1 Year D4
p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI)
Country
UK and Ireland 0.017 0.47 (0.26–0.88) 0.026 0.48
b
(0.25–0.92)
0.307 0.74(0.41–1.32) 0.136 0.64 (0.36–1.15)
USA 0.033 0.61 (0.28–0.94) 0.148 0.71 (0.44–1.13) 0.614 1.12(0.73–1.71) 0.490 0.86 (0.56–1.32)
Canada 0.017 0.47 (0.43–0.51) 0.630 0.86 (0.61–1.11) 0.350 1.30(0.79–1.81) 0.969 1.01 (0.45–1.48)
Australia 0.318 0.65 (0.68–2.03) 0.623 0.80 (0.33–1.94) 0.939 1.03(0.48–2.23) 0.767 1.13 (0.51–2.49)
Cont. Europe a – a – a – a – a
Location
Rural 0.766 1.06 (0.72–1.56) 0.061 1.45 (0.98–2.14) 0.892 0.98(0.69–1.39) 0.260 1.23 (0.86–1.76)
Urban 0.786 0.96 (0.72–1.28) 0.322 1.16 (0.86–1.57) 0.451 0.91(0.70–1.17) 0.440 1.11 (0.85–1.44)
Sub-urban a – a – a – a – a
Practice type I Mixed 0.155 1.35 (0.89–2.05) 0.149 1.37 (0.89–2.09) 0.012
1.64
(1.12–2.41) 0.01 1.67 (1.13–1.47)
SA a – a – a – a – a
Practice type II
Referral/Uni 0.404 1.23 (0.75–2.01) 0.367 0.78 (0.45–1.34) 0.045 1.59(1.01–2.49) 0.232 1.32 (0.84–2.09)
Charity 0.023 2.18 (1.11–4.27) 0.002 2.93 (1.49–5.78) 0.028 2.05(1.08–3.87) 0.047 1.92 (1.01–3.66)
Private a – a – a – a – a
% insured
>20% 0.556 1.18 (0.68–2.03) 0.588 1.17 (0.66–2.08) 0.991 1.00(0.61–1.65) 0.195 0.72 (0.43–1.19)
<20% a – a – a – a – a
CI—confidence interval; a Reference category; Bold: Statistically significant association (p < 0.05).
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“Percentage insured” (with a 20% cut-off) was found not to be significantly associated with
answers to any of the four assessed questions (D/C 1, 2, 3, 4). Cats presented to practices in Canada
(odds ratio (OR) 2.7) and Australia (OR 2.3) as well as in rural (OR 1.6) and mixed (OR 1.7) practices
were more likely to be euthanased because of DM diagnosis, while cats presented to referral centres or
UTH were at lower risk (OR 0.6). Dogs were more likely to be euthanased because of DM in Canada
(OR 1.8) and if they were presented to rural (OR 1.8) and mixed (OR 1.6) practices. Cats and dogs
presented to practices in Canada (OR for cats 2.4, OR for dogs 2.1) and to rural practices (OR for both
cats and dogs 2.2) were at higher risk to be euthanized on owner request because of not wanting to
treat with insulin injections; the risk was lower for cats presented to referral centres or universities
(OR 0.54). Treatment of DM was less likely to be ceased within the first month of diagnosis because
of lack of success or compliance in cats presented to practices in Canada (OR 0.5), USA (OR 0.6) and
UK and Ireland (OR 0.5) and in dogs in UK and Ireland (OR 0.5). On the other hand, both cats and
dogs were more likely to have DM treatment stopped within 1 month (OR for cats 2.2, OR for dogs 2.9)
and within 1 year (OR for cats 2.0, OR for dogs 1.9) of DM diagnosis if presented to charity practices.
Being presented to a mixed practice increased the risk for treatment cessation within 1 year in both
cats (OR 1.6) and dogs (OR 1.7). The risk of treatment cessation within 1 year of DM diagnosis was
also higher for cats presented to referral or university hospitals (OR 1.6).
4. Discussion
The Big Pet Diabetes Survey is the first of its kind to document perceptions of veterinarians on
frequency and reasons for euthanasia of diabetic cats and dogs at the time of diagnosis and within the
first year of treatment. Furthermore, the study also obtained information about DM treatment habits
as well as clinician’s and perceived owner’s concerns.
The study revealed that according to the interviewed population of veterinarians, a median of one
in 10 cats and dogs with DM were euthanased on request of the owner at the time of diagnosis and in
another median of one in 10 cats and dogs, treatment was stopped within one year because of lack of
response or compliance. Although the frequency of euthanasia within the first month of DM diagnosis
in this study (0–1 of 10 cats and dogs) was comparable to previous reports in cats (mortality rates
of 11%–17% within first 3–4 weeks) [5,7], higher figures were reported in a large Swedish insurance
study concerning diabetic dogs [3]. In the latter investigation, 30% of dogs were euthanased at time
of diagnosis and another 15% within 30 days. Mortality rates within 1 year of DM diagnosis were
found to be 35%–40% in cats [4,5,7] and 60% in dogs in the above mentioned Swedish study [3], which
is higher than in the present investigation. This might be attributable to demographic and temporal
differences, previous studies concerning cats presented to UTHs in the USA and Switzerland [5–7] and
primary-care veterinary practices in the UK [4] and diabetic dogs in Sweden [3].
In hindsight, there might have been advantage to re-phrasing the euthanasia-questions to state
“out of 20” instead of “out of 10”, allowing for more detailed assessment of the most common answers,
which were mostly around the one out of 10. Comparison of the current data with other studies or
extrapolation to other diabetic pet populations should therefore be performed with caution, especially
in view of the demonstrated interacting demographic characteristics. Higher proportions of euthanasia
cases or treatment cessations were reported to occur amongst newly diagnosed cats and dogs in
Canada and Australia, in rural, mixed and charity practices, and a lower proportion in referral or
UTH. These findings could relate to differing client perceptions and expectations or attitudes amongst
different countries and practice types, as well as possibly differing economic factors. Additionally,
results of our study could also imply that should a greater proportion of respondents have originated
from outside the USA, UK and Ireland or Continental Europe, and/or from rural, charity and mixed
practices, a different picture might well have been recorded, with a trend towards more euthanasia and
cases of premature cessation of treatment. Educational programmes focussed on offering a variety of
DM management styles (ranging from intense and expensive to relatively hands-off) might positively
affect these increased euthanasia rates, although the current dataset does not provide direct proof
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for this. Interestingly, despite the majority of clinicians suspecting clients to be more likely to opt for
insulin treatment if their animal is insured, the insurance level did not seem to significantly influence
treatment decisions.
When considering euthanasia, “concurrent disease”, “costs” and “age” were reported to be the
most important factors for owners, whereas “injection problems” were considered to be the least
important. The latter is also in alignment with the results of the concurrently performed QoL survey
conducted among owners [1,2]. Older age was negatively associated with survival in a previous
report [5] and cats with concurrent disease had 70% higher mortality rate in comparison to those
without [7], substantiating the results of the current survey. The requirement for multiple practice
visits, blood sampling and daily treatment administration associated with current treatment regimens
would also justify the perceived importance of “costs”. Interestingly, “too much impact on owner’s
lifestyle” was also considered of importance by most clinicians, which is in line with research among
diabetic pet owners, where it featured dominantly among the top 10 items with negative impact on
QoL constructed by owners themselves [1,2].
In general, there are only limited data available on compliance issues in veterinary medicine
with most information extrapolated from human research [8]. Although it is generally accepted that
a high level of owner and pet compliance is essential for successfully treating any disease and most
particularly DM [9,10], no work has previously assessed the relative importance of specific compliance
issues in managing canine and feline diabetics. The current data suggest most common compliance
issues include adherence to feeding protocols and injection difficulties.
Quality of life of the animal was considered the most important concern in regard to DM for both
owners and clinicians in this study, and based on clinicians’ experience, a small proportion of owners
perceived the QoL of their animal or their own lifestyle to be unsatisfactory after starting the insulin
treatment. “Costs of treatment” and “having to inject their animal” featured prominently on the list of
owners’ concerns according to the experience of surveyed clinicians, which was in contrast with the
owner data derived from the QoL survey [1,2]. This might represent a difference between populations
of owners in these survey studies, and possibly also clinicians’ misconception of owners’ perceptions.
Indeed, clinicians would have responded from their experience with both owners who proceed with
long-term insulin injections (possibly similar to the QoL survey respondents) and those that have
discontinued treatment in the short-term.
Clinicians themselves were more frequently concerned about hypoglycaemia and DKA, which
might reflect their perception of these complications as being serious and possibly life-threatening.
Hypoglycaemia was reported to occur in two out of 10 cats and dogs in the present study and one in
10 cats and dogs suffered from DKA. The latter complication was reported to have occurred in 12%
and 34% of cats with DM presented to UTHs [6,7]. This represents further indications of remaining
room for improvement in current treatment methods.
There are a number of limitations to this study. Information surrounding the frequency and
reasons for the owner to opt for euthanasia or treatment cessation was gained by asking veterinarians,
rather than obtaining this information from owners directly or by analysing veterinary practice records.
Unfortunately, approaching a large number of such owners would have been difficult, since in most
cases they were unlikely to have reasons to continue to attend their veterinary practice. Therefore,
for such information to become available, it seemed a logical alternative to record the experiences of
veterinarians dealing with both compliant and non-compliant diabetic animals and their owners on a
regular basis.
Additionally, the possibility exists for this study to be affected by so-called recall bias. It could,
for instance, be envisioned that this has led to lowering of the reported frequency of euthanasia when
predominantly asking those clinicians with a positive past experience in treating diabetes (or vice versa).
Indeed, most clinicians reported they would treat their own pet if diagnosed with diabetes, indicating
such possible positive past experience. However, obtaining this type of information from medical
records of veterinary practices on three different continents would have been extremely difficult. Some
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of the information could have been obtained from large database systems such as the Veterinary
Medical Database (VMDB) in North America or VetCompass in the UK; however, the former would
have introduced bias towards university teaching hospitals (shown to be a possible confounding
factor in the current study) and the latter had just been launched at the time of performing this
survey. Experience in working with the VetCompass database also reveals that accurate information
surrounding reasons for euthanasia is infrequently recorded; nevertheless, a future study based on
VetCompass should be considered. Records of insurance companies could have represented another
alternative, however, would have been limited to an insured population.
Finally, the current study used a questionnaire consisting of closed-ended questions. This might
have biased clinicians’ responses, despite offering the option “other” to provide additional information.
However, the use of open-ended questions is associated with higher risk of larger item non-response
or invalid answers resulting in missing data [11]. When analysing these free text contributions, no
major and consistent misunderstandings or omissions were identified, confirming the validity of
the initial design of the Big Pet Diabetes Survey. Therefore, although the limitations of the current
approach should be kept in mind, the obtained data adds unique large-scale insight to the knowledge
surrounding this topic.
5. Conclusions
In conclusion, the Big Pet Diabetes Survey records the perceived treatment cessation and
euthanasia rates in companion animals diagnosed with DM amongst a large number of clinicians
in a large number of countries. The causes behind country- and practice-type-associated differences
should be further investigated. In view of the recorded perceived factors driving euthanasia instead
of (continued) treatment, designing novel and more successful DM treatment protocols and options
would be desirable; ideal treatment characteristics would include being less expensive, rapidly effective
whilst carrying a low hypoglycaemia-risk and with decreased impact on owner lifestyle.
Supplementary Materials: The following are available online at http://www.mdpi.com/2306-7381/4/2/27/s1,
Supplement 1—The Big Pet Diabetes Survey, Supplement 2—Results of univariate analysis for the main treatment
decision questions (D/C 1-4).
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